Goodwin Procter LLP advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 10,575,513 shares of its common stock, including…
Adicet Bio, Inc.’s $137.5 Million Rights Offering
Goodwin Procter LLP advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 10,575,513 shares of its common stock, including…